ZJYL NASDAQ
Jin Medical International Ltd.
1W: +4.2%
1M: -5.2%
3M: +0.5%
YTD: +784.0%
1Y: +250.3%
3Y: +107.5%
$1.94
-0.06 (-3.00%)
Weekly Expected Move ±9.3%
$2
$2
$2
$2
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Revenue Segmentation
By Product / Service
Income Trends
Revenue
$21M
-12.0% ▼
5Y CAGR: +5.0%
Gross Profit
$6M
-36.4% ▼
5Y CAGR: +1.9%
Operating Income
$608K
-83.3% ▼
5Y CAGR: -23.7%
Net Income
$1M
-67.6% ▼
5Y CAGR: -11.6%
EPS (Diluted)
$0.15
-68.1% ▼
5Y CAGR: +93.7%
EBITDA
$933K
-76.6% ▼
5Y CAGR: -19.7%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $21M | $19M | $20M | $24M | $21M |
| YoY Growth | +28.2% | -7.6% | +3.3% | +18.6% | -12.0% |
| Cost of Revenue | $14M | $13M | $13M | $14M | $15M |
| Gross Profit | $6M | $6M | $7M | $10M | $6M |
| Gross Margin | 30.6% | 32.3% | 34.2% | 40.4% | 29.2% |
| R&D Expenses | $2M | $2M | $2M | $1M | $2M |
| SG&A Expenses | $2M | $2M | $2M | $4M | $4M |
| Operating Expenses | $4M | $4M | $4M | $6M | $5M |
| Operating Income | $3M | $2M | $3M | $4M | $608K |
| Operating Margin | 12.7% | 11.1% | 14.5% | 15.5% | 2.9% |
| Interest Expense | $9K | $0 | $0 | $0 | $0 |
| Income Before Tax | $3M | $3M | $3M | $4M | $2M |
| Tax Expense | $249K | $36K | $344K | $764K | $215K |
| Net Income | $3M | $3M | $3M | $4M | $1M |
| Net Margin | 12.7% | 14.1% | 14.5% | 15.6% | 5.8% |
| EPS (Diluted) | $0.01 | $0.02 | $0.02 | $0.02 | $0.15 |
| EBITDA | $3M | $3M | $3M | $4M | $933K |
| Shares Outstanding | 268M | 135M | 145M | 156M | 8M |